Na Cocer Peptides rayt am 
25 dez bifo.
biyכn di kכr domεn dεm lεk mεtabolik rεguleshכn εn imyun anti-inflameshכn, pεptida sכbstans dεm de sho yunik valyu insay spεshal sεnariכ dεm we inklud rεspiretכri sik intavεnshכn, kכdivaskyul fכnshכn protεkshכn, εn εkspεriεns risεch tul divεlכpmεnt, biכs fכ dεn hכy strכkchכral divεrsiti εn bayolojikal aktiviti. dis aplikεshכn dεm de brok tru di limitεshכn dεm fכ tradishכnal drog dεm, de gi nyu sכlushכn fכ komplεks sik tritmεnt εn bεsik sayntis risεch tru tכgεt mכkus rεpa in di rεspiretכri sistεm, rεguleshכn fכ di kכdivaskyul sεl signal path dεm, εn prεsis kכntrכl fכ εkspεriεns mכdel dεm. di kכr advantej dεm we dεn gεt—hεy tכgεt spεsifisiti, lכw imyunojenisiti, εn kכstכmayzεbl sεntesis—dεn de drεb di kכros-disiplinari εkspεnsכn fכ pεptida dεm frכm klinik tεrapi to mכltidisiplinari aplikεshכn dεm.
Figure 1. Skematik rεprεsεntεshכn fכ di patכlayz imyun rεspכns na di aywe dεm. Sos: Proinflammatory Cytokines in Kronik Respiratory Disiz ɛn Dɛn Manejmɛnt (2025).
Di say dɛn we yu fɔ yuz am
1. Respiratory System: Ripair εn Inflamεshכn Rεgulεshכn
fכ sik dεm we nכ de kכmכt lεk krכnik obstruktiv pulmonari sik (COPD), pulmonary fibrosis, εn alerjik asma, pεptida sכbstans dεm de wok tru anti-inflamεshכn, antioksidεshכn, εn mכkus rεpa.
Airway mucosal protɛkshɔn ɛn ripa
di brכnkial ripa pεpti dεm de protεkt di aywe εpitεlial sεl proliferashכn εn tayt jכnkshכn protin sεntesis bay we dεn de aktibכt di epidamal growth fכktכ rεsεptכr εn transfכm di gכt fכktכ-β path dεm, we de ripεr di mכkus dεm we dεn kכz fכ smok כ pכlyushכn. di inhibishכn we dεn de inhibishכn fכ nyutrofil kεmotaktik fכktכ dεm de ridyus di aywe inflammatory rεspכns dεm na di pasεnshכn dεm, we de dכn di frεkuεns fכ akyu exacerbations.
di antimaykrobial pεpti dεm (εgz., LL37 dεrivεt dεm) de ridyus di risk fכ pulmonari infεkshכn insay sistik fכbrosis bay we dεn de disrupt Pseudomonas aeruginosa bayofilm dεm εn rεgεl makrofag fagosaytosis. dεn de inhεbit bak fכ rilis fכ inflammatory fכktכ dεm pasmak, we de delay di prכgreshכn fכ pulmonary fibrosis.
Pulmonary fibrosis intavɛnshɔn
di pineal rεgεdyushכn pεpti dεm (εgz., Pinealon) de inhεbit εksyכs aktibכshכn fכ di lכng fכblas dεm bay we dεn de rεgεl di maytochכndrial fכnshכn εn tεlomεrayz aktvכti, we de ridyus abnכmal dεposishכn fכ tayp I kolagen εn fibronectin. insay bleomycin-induced pulmonary fibrosis mכdel dεm, dεn de sכmtεm mitigate di alvεolar septal tikεn εn impruv di lכng fכnshכn.
2. Kadivaskyul Sistem: Vaskul Protεkshכn εn Mayokardial Ripa
fכ sik dεm lεk atεrosklεrosis, mayokardial infarkshכn, εn at fεil, pεptida sכbstans dεm de wok bay we dεn de rεgεl angiojεnεsis, anti-mayokardial apoptosis, εn impruv εnεji mεtabolism.
Angiojenεsis εn εndoteyl protεkshכn
di angiojenik pεpti dεm de mεk di fכnshכn we di vaskulεr εndoteyl gכt fכktכ de du, we de protεkt εndoteyl sεl proliferashכn, maygrεshכn, εn lumen fכmeshכn. insay ischemic hat sik, dεn de indyuz kolataral sεkyuleshכn fכmeshכn fכ impruv di mayokardial bכdi saplai. di aktibכshכn we dεn de mek fכ di vaskulεr εndoteyl nitric oksayd sεntez de εnhans di vaskulכr dilayshכn εn i de ridyus di risk fכ fכm di atεrosklεrotik plek.
di kadyoprotεktiv pεpti dεm (εgz., Corgaten) de tכk to di mayokardial maytochכndrial mεmbran dεm, we de inhεbit saytokrכm C rilis εn apoptosis path aktibכshכn. dis de ridyus di mayokardia sel nεkrכsis we de kכz bay ischemia-riperfyushכn injuri, i de impruv di kadyak sistolik fכnshכn afta mayokardial infarkshכn, i de dכn di fibrosis εria, εn i de delay di hat fεil prכgreshכn.
Antitrombotik ɛn lipid rɛgyuleshɔn
RGD-dεriv pεpti dεm de inhεbit pletlet agregεshכn bay we dεn de blכk di binding fכ pletlet sεf integrin dεm to fibrinogen, we de sεv as ki mכlikul dεm insay di divεlכpmεnt fכ nכvel antithrombotic dכg dεm. Dɛn advantej de pan di smɔl risk fɔ blɔd we yu kɔmpia am wit tradishɔnal antikoagulant.
Figure 2. di kכmכpכnt dεm fכ di vasopressin sistεm we de involv fכ rεgεl di bכdi fכ fכlכ na di bren, at, vεsul dεm, kidni, lכng dεm εn dijestiv sistεm. AVP—arginin vasoprɛsin; SNS—di nεv sεstem we de mek pɔsin fil sɔri; V1aR—vasopresin V1a risεptor dεm; V1bR—vasopresin V1b risεptor dεm; V2R—vasopresin V2 risεptor dεm. Sos: Di At as Target fɔ Vasopressin ɛn Ɔda Kadiɔvaskyuɛl Pɛptyd dɛn na Wɛlbɔdi ɛn Kadivaskular Diziz (2022).
3. Ekspirimɛnt Risach: Divɛlɔpmɛnt ɛn Aplikeshɔn fɔ Prɛsishɔn Tul Pɛptayd dɛn
insay besik mεdisin εn dכg divεlכpmεnt, pεptida sכbstans dεm de sav as efyushכn tul mכlikul dεm fכ advans prεsis mεkanism risεch εn mכdel kכnstrכkshכn.
Signaling pathway prob dɛn
sכm pεpti dεm (εgz., Src kinase inhibitory peptides) spεshal wan de blכk di aktvכti fכ Src famili kinaz dεm, we dεn yuz fכ stכdi signal transdyushכn mεkanism dεm insay sεl proliferashכn εn maygrεshכn. dεn hכy afiniti de mek spatiotemporal prεsis rεgulεshכn fכ spεsifi k path dεm.
G protin-kכpl rεsεptכr (GPCR) ligεnd pεpti dεm (εgz., PT141 analכg dεm)
dis pεpti dεm de yuz fכ dεsεkt GPCR-mεdiet sεlyul signal transdyushכn nεtwכk dεm, we de gi mכdel fכ skrεn dכg tכgεt dεm na mεtabolik sik dεm.
Dɔn
di aplikeshכn fכ pεptida sכbstans dεm na כda spεshal aplikεshכn dεm de hεlayt di adaptabiliti εn inovashכn fכ dεn mכlikul dεm ya insay kכros-disiplinari sεnariכ dεm. insay di rεspiretכri sistεm, dεn de gi εnd-to-εnd protεkshכn frכm mכkus rεpa to fibrosis intavεnshכn; insay kadiolכji, dεn de brok tru tradishכnal tεrapi bכtlεn dεm via angiojεnεsis εn mayokardial protεkshכn; insay εkspεriεns risεch, dεn de akt lεk prεsishכn tul dεm fכ advans mεkanism analisis εn dכg diskכvri. dis aplikεshכn dεm nכ de כnli ful tritmεnt gap fכ spεsifi k sik dεm bכt dεn de sho bak di brij rol we pεptida sכbstans dεm de ple na bεsik risεch εn klinik transleshכn.
ƆL DI ATIKUL ƐN PRODƆKT INFƆMƐSHƆN WE DƐN GI NA DIS WƐBSAYT NA FƆ ƆL FƆ DI INFƆMƐSHƆN ƐN FƆ EDYUKESHƆN.
Di prɔdak dɛn we dɛn gi na dis wɛbsayt na fɔ in vitro risach nɔmɔ. in vitro risach (Latin: *in glas*, we min insay glas) dεn de du am ausayd mכtalman bכdi. Dɛn prɔdak ya nɔto famasitik, dɛn nɔ gɛt di aprɔval frɔm di US Food and Drug Administration (FDA), ɛn dɛn nɔ fɔ yuz dɛn fɔ protɛkt, trit, ɔ mɛn ɛni mɛrɛsin, sik, ɔ sik. Di lɔ nɔ gri fɔ mek dɛn put dɛn tin ya insay mɔtalman ɔ animal bɔdi ɛni we.
